DURHAM, N.C. — BioSkryb Genomics, a pioneer in single-cell and ultra–low-input multiomic solutions, together with Eremid® Genomic Services, a specialty high-complexity genomics contract research organization and BioSkryb Certified Service Provider (CSP), today announced the launch of an Early Access Program for BioSkryb’s new ResolveSEQ LongRead solution. Through this program, researchers will gain access to services […]
FREDERICK, Md. and PLANO, Texas — RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and Secretome Therapeutics, a clinic-stage company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC), today announced completion of commercial scale production of Secretome’s lead nCPC, STM-01. In March 2025, […]
Anticipated collaboration with leading academic institutions aims to overcome key barriers in cell and gene therapy by targeting solid tumors, enabling in vivo treatment, and radically reducing manufacturing costs Cytiva (Global Life Sciences Solutions USA, LLC), a Danaher company and a global leader in the life sciences industry, will lead a new effort aiming to […]
Highly scalable, cost-effective LongPlex™ kit delivers streamlined tagmentation and multiplexing for low-pass whole genome sequencing, plasmid resequencing, and microbial sequencing MENLO PARK, Calif. — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced an expanded partnership with seqWell, a global provider of genomic library and multiplexing workflow solutions. Under the […]
Launch of End-to-End Workflow for AVITI and AVITI24™ Enabling Sample to Sequencer in as Little as Five Hours — Twist Gains Exclusive Access to the new, co-developed Trinity Freestyle™ Sequencing Workflow – SOUTH SAN FRANCISCO, Calif. & SAN DIEGO–Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, and Element Biosciences, Inc., a […]
MaxCyte’s Flow Electroporation® Technology will support efficient gene delivery to advance Moonlight Bio’s engineered T cell therapies ROCKVILLE, Md. — MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics, today announced the signing of a Strategic Platform License (SPL) agreement with […]
WILMINGTON, N.C. — The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new research and development (R&D) partnership with the AstraZeneca BioVentureHub in Gothenburg, Sweden. Thermo Fisher Bioanalytical lab The partnership aims to leverage the combined expertise of Thermo Fisher and AstraZeneca to drive innovation and […]
Strategic partnership provides complete automation-friendly solution for IDT NGS workflows on Hamilton’s liquid handling systems and enables user choice for solid tumor, heme comprehensive genomic profiling and more BOULDER, Colo. — To equip users with a complete next generation sequencing (NGS) solution from sample to answer, global genomics leader Integrated DNA Technologies (IDT), together with Hamilton (Hamilton Company […]
WOBURN, Mass. — Cell X Technologies today announced a collaboration with BioLamina to integrate BioLamina’s defined laminin reagents (Biolaminin®) with Cell X’s Celligent™ platform, aiming to reduce variability and enhance reproducibility in advanced therapy manufacturing. This collaboration underscores the critical role of pairing automation with high-quality, standardized reagents in building scalable, reliable, and GMP-compliant workflows for […]
The collaboration combines multimodal database technology, advanced AI agents, and large-scale datasets to accelerate drug discovery. TileDB, Inc., Kepler AI, and Tahoe Therapeutics today announced a groundbreaking partnership to create the first public-facing platform that enables researchers to run sophisticated AI agent-based queries on massive single-cell datasets at unprecedented scale. This collaboration represents a major […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
